LSLeming Shi

Leming Shi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leming Shi has a total of 933 co-authors. Here are the top co-authors by number of shared publications:

  • Yuanting Zheng

    State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences and Human Phenome Institute, Fudan University, Shanghai, China

    50 shared publications
  • Ying Yu

    State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences and Human Phenome Institute, Fudan University, Shanghai, China

    32 shared publications
  • Yaqing Liu

    State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences and Human Phenome Institute, Fudan University, Shanghai, China

    25 shared publications
  • Wanwan Hou

    State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences and Human Phenome Institute, Fudan University, Shanghai, China

    20 shared publications
  • Yuanting Zheng

    State Key Laboratory of Genetic Engineering School of Life Sciences and Human Phenome Institute Fudan University Shanghai China

    20 shared publications
  • Luyao Ren

    State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Human Phenome Institute and Shanghai Cancer Center, Fudan University, Shanghai, China

    19 shared publications

Latest Publications

  • Open Access

    Endpoint-Aware Workflows to Detect and Quantify Isoforms and Alternative Splicing by RNA Sequencing

    by Qingwang Chen, Xiaorou Guo, Ziyu Cao, Duo Wang, Yaqing Liu, Wanwan Hou, Yutong Zhang, Shumeng Duan, Yadong Liu, Ying Yu, et al.

    Alternative splicing and transcript isoform diversity expand the regulatory information captured by transcriptome profiling beyond gene-level expression. However, the reliable detection and quantification of isoforms and alternative splicing using RNA sequencing is complex and not determined by a single platform or computational tool. It is a workflow-centered measurement problem in which the analytical endpoint, RNA integrity, enrichment and library construction, sequencing strategy, computational analysis, benchmarking, and validation jointly determine the confidence of a research finding. This review reframes transcript-resolved sequencing in terms of endpoint-aware workflows, distinguishing among isoform discovery, isoform quantification, splicing event detection, differential isoform expression, differential transcript usage, and differential alternative splicing events. We compare short-read, long-read, and hybrid sequencing strategies across the experimental and computational decisions that most strongly affect reliability. We further discuss RNA reference materials, matched reference datasets, quality metrics, and orthogonal validation as recurring elements of workflow evaluation. An endpoint-aware reliability framework can help transcript-resolved studies progress from feature detection to reproducible, benchmark-supported, and biologically interpretable inference.

  • Open Access

    An East Asian blood eQTL meta-analysis highlights ancestry-matched eQTL resources for complex-trait genetics

    by Jie Wang, Zhengyuan Li, Ruixian Yang, Ying Yu, Huidan Chang, Leming Shi, Liyun Yuan, Fang Zhou, Guoqing Zhang, Li Jin, et al.

    Expression quantitative trait loci (eQTLs) link genetic variation to gene regulation and complex traits, yet population-scale blood eQTL resources remain limited in East Asian populations. We mapped cis-eQTLs in 1,005 Chinese individuals and meta-analysed them with a Japanese cohort to generate an East Asian whole-blood resource (MAEEA; n = 2,024). MAEEA identified ∼2.8 million cis-eQTL associations involving 13,376 eGenes, with lead effects showing external concordance, including in an independent East Asian cohort. For East Asian complex traits, MAEEA showed greater utility than larger non–East Asian eQTL resources for heritability partitioning and candidate gene–trait prioritization; reciprocal analyses using phenotype-matched European GWAS were consistent with ancestry matching contributing to these differences. Highly differentiated eQTL SNPs showed evidence consistent with recent positive selection, and trait-associated eQTL SNPs were enriched for elevated population differentiation. These findings expand East Asian regulatory genetic resources and support ancestry-matched eQTL data for complex-trait interpretation.

  • Ensuring multiomics data reproducibility for artificial intelligence with reference materials as a common calibrator

    by Leming Shi, Wenjun Bao, Aedín C. Culhane, Xiang Fang, Cesare Furlanello, Ruixin Hao, Wendell D. Jones, Rebecca Kusko, Samir Lababidi, Christopher E. Mason, et al.


  • Open Access

    Distinct multi-omics signatures of clinical subgroups of type 2 diabetes define heterogeneous responses to an insulin sensitizer

    by Zehui Cao, Ruolan Zhang, Haonan Chen, Naixin Zhang, Qiaochu Chen, Yuanbang Mai, Xintong Yao, Qingwang Chen, Jiaqi Li, Desi Pan, et al.

    Type 2 diabetes (T2D) subgroups defined by clinical variables differ in disease progression and treatment response. To uncover potential molecular drivers of this heterogeneity, we performed a multi-omics analysis of 826 drug-naïve T2D patients from two phase 3 trials of the insulin sensitizer chiglitazar. Here we show that severe insulin-resistant diabetes (SIRD) is characterized by distinct miRNA profiles (e.g., miR-122-5p) correlated with liver injury, and metabolic shifts in amino acids and primary bile acids. Mild obesity-related diabetes (MOD) showed the lowest level of phenylacetylglutamine, a metabolite known to promote cardiovascular disease. Severe insulin-deficient diabetes (SIDD) exhibited high pancreas-specific miR-7-5p, while mild age-related diabetes (MARD) presented the mildest abnormalities. Finally, integrating these multi-omics signatures into machine learning models enhanced prediction of insulin sensitizer efficacy over clinical data alone. Our findings define the distinct molecular signatures of T2D subgroups, facilitating the prediction of heterogeneous treatment responses and supporting personalized clinical management.


  • Open Access

    Plasma titration provides a physical ruler for cross-platform proteomics

    by Yaqing Liu, Haiyan Wang, Yutong Zhang, Renquan Lu, Weihong Xu, Wanwan Hou, Yuyang Zhu, Xixi Li, Qingwang Chen, Yuechen Gao, et al.

    Plasma proteomics is expanding across platforms and cohorts, and integrating these data for AI demands comparability at the protein level, not merely concordant associations 1,2 . Affinity and MS platforms use distinct probes (antibodies, aptamers, or peptides) and signal readouts, yielding contradictory cross-platform results 3,4 . Without a known quantitative truth, we cannot distinguish biology from measurement distortion, leaving no gold standard for integration. Here we introduce Plasmix—a plasma reference suite with predefined male:female ratios (M, 1:0; Y, 3:1; P, 1:1; X, 1:3; F, 0:1)—and show that preserving this quantitative titration gradient, not just technical repeatability, predicts cross-platform concordance and identifies protein measurements suitable for integration. Profiling Plasmix across five platforms (Olink, SomaScan, NULISA, AAgAtlas, and MS-DIA) and 12 protocols across 17 batches, we found discordance is dominated by signal generation, not sample identity, and platforms distort signals in a protein-specific manner. Crucially, proteins retaining the titration response showed stronger agreement in an independent cohort; anchoring to the Plasmix midpoint (P) via sample-to-reference ratios reduced distortions, extending harmonizable coverage by 10–20%. Plasmix thus provides a physical ruler to benchmark accuracy, identifying genuinely integrable measurements before pooling datasets or training AI models—a critical bottleneck for plasma proteomics.


  • Open Access

    Benchmarking RNA-seq with the Quartet and MAQC reference materials to establish best practices for accurate alternative splicing analysis

    by Duo Wang, Jiaxin Zhao, Qingwang Chen, Yanxi Han, Yaqing Liu, Yuanfeng Zhang, Cong Liu, Wanwan Hou, Ying Yu, Leming Shi, et al.

    Previous limited characterization of short-read RNA-seq (srRNA-seq) accuracy in alternative splicing (AS) analysis due to methodological diversity and lack of reference standards, has left unclear how to achieve optimal performance—an issue increasingly critical with the rise of long-read sequencing. To address this, we conduct a large-scale reference-based benchmarking study across 42 laboratories and 207 analysis pipelines leveraging the Quartet and MAQC reference materials. Here, we show that high data quality and depth improved the accuracy of splice junction detection, as well as isoform- and event-level quantification and differential analysis. Best practices for experimental and bioinformatic design are identified, with optimal pipelines achieving Pearson and Matthews correlation coefficients of 0.79 and 0.68 for isoform-level quantification and differential analysis, and 0.41 and 0.41 for event-level analyses, respectively. This corresponds to improvements of 0.21–0.45 and 0.51–0.67 at the isoform level, and 0.09–0.27 and 0.16–0.34 at the event level relative to the poorest-performing pipelines across laboratories. Beyond technical workflows, low expression or coverage and high compositional complexity represent general constraints on accuracy. Collectively, this study provides practical guidance for maximizing AS profiling accuracy with existing methodologies, contributing to effective srRNA-seq application in RNA splicing research.


  • Open Access

    Benchmarking Q40 sequencing for sensitive and efficient detection of rare genomic variants

    by Shumeng Duan, Yaqing Liu, Xiaorou Guo, Zhiyin An, Ruiwen Ma, Qiaochu Chen, Yanming Xie, Qingwang Chen, Ying Yu, Lianhua Dong, et al.

    Phred quality score (Q score) is critical for sequencing accuracy, yet the impact of Q40-achieving sequencing technologies (99.99% accuracy) on detecting subtle biological variations remains unvalidated. Using a comprehensive set of well-established DNA/RNA reference materials (Quartet, NIST-RM8398, SEQC2-HCC1395/BL, MAQC, and ERCC), we benchmarked Q40 sequencing (Element AVITI) against the conventional Q30 standard (Illumina NovaSeq 6000). Q40 reduced required sequencing depth by 33.3% while maintaining accuracy for germline variants (20 × vs. 30 ×) and somatic single-nucleotide variant/insertion-deletion (SNV/InDel) (60 × vs. 90 ×). Crucially, Q40 enhanced sensitivity for low-frequency somatic mutations (variant allele frequency, VAF ≤ 0.2) by 33.3% and sixfold higher copy number variation (CNV) detection reproducibility (60.3% vs. 10.4%) with Q40 at 30 × depth, directly reducing per-sample volumes by 33.3-60% and theoretically reducing sequencing costs by 2.2-31.7%. In addition, Q40 improved the discriminatory resolution between biological samples with 13.1% signal-to-noise ratio (SNR) enhancement. Taken together, our findings establish the value of Q40 sequencing as a sensitive and cost-effective method for low-frequency variant detection. While this positions it as a promising tool for precision oncology, its performance in real-world clinical applications remains to be evaluated in future studies.

  • Open Access

    A metrological foundation for absolute transcriptomics using International System of Units-anchored calibrators

    by Yu Zhang, Bingwen Yang, Ying Yu, Xia Wang, Chunyan Niu, Yongzhuo Zhang, Yang Liu, Jingshu Li, Caihang Zhang, Jiayi Yang, et al.

    RNA-sequencing's conversion of molecules to reads is inconsistent. Experiment-to-experiment variations (systemic bias) create batch effects, while gene-to-gene variations (sequence-dependent bias) invalidate inter-gene comparisons, precluding a universal scale. This confines analysis to relative fold-changes, a metric unreliable across batches. We introduce TranScale: 100 biomimetic standards with SI-traceable concentrations certified by Isotope Dilution Mass Spectrometry. Co-processed within samples, they empirically characterize systemic and sequence-dependent biases, generating a library-specific calibration curve (R² > 0.97) to convert reads into absolute quantities. This approach reveals that consistent fold-changes can mask severe absolute errors, exposing systemic biases missed by conventional QC. Across laboratories, this calibration reduced median inter-lab CV from >85% to 7.9, outperforming the widely-used tool ComBat. By anchoring RNA-seq to the SI, our work establishes the metrological foundation for data interoperability and universal benchmarks, enabling absolute comparisons of SI-traceable quantities between any two genes.


  • Open Access

    Integrative clinico-molecular analysis reveals actionable subtypes and biomarkers in lung adenocarcinoma

    by Jun Shang, He Jiang, Yueren Yan, Yue Zhao, Jingcheng Yang, Han Han, Hui Yuan, Leming Shi, Yuanting Zheng, Haiquan Chen

    Deeper insights into omics in the clinical and tumor microenvironments of lung adenocarcinoma (LUAD) could reveal therapy-sensitive subtypes and novel treatments. From a cohort of 1008 samples from Chinese patients with LUAD with whole-genome and transcriptome sequencing data along with comprehensive longitudinal clinical and therapeutic information, we identified four prognostically distinct subtypes, namely, low proliferation and invasion (LPI), immune-desert (IMD), immune-enriched (IME), and high proliferation and invasion (HPI), based on the transcriptomic features linked to the radiological, pathological, and microenvironmental dimensions. Compared with chemotherapy, tyrosine kinase inhibitor (TKI) therapy demonstrated significantly superior efficacy for LPI and IMD, whereas no such difference was observed for HPI. VOPP1 and RRM2B amplification were closely associated with TKI resistance and sensitivity, respectively. VOPP1 knockdown restored sensitivity to TKI treatment, while RRM2B knockdown induced TKI resistance, and its overexpression restored sensitivity. Patients with RRM2B amplification had a 5-year survival rate of nearly 100%. Additionally, the IME subtype exhibited higher immune checkpoint activity and a higher frequency of DYNC2H1 mutation, with patients benefiting from immunotherapy. These findings provide critical insights into LUAD treatment optimization.


  • Open Access

    Mechanisms of Aristolochic Acid Resistance in Specialist Butterflies and Evolutionary Insights for Potential Protective Pathways

    by Yang Luan, Yubo Zhang, Jingjing Li, Jianqing Zhu, Yuyang Lei, Yushi Hu, Zhenqiang Xin, Tianpei Xie, Jiang Zheng, Yuanyuan Lin, et al.

    Aristolochic acids (AAs) are natural compounds found in Aristolochiaceae plants, to which humans are frequently exposed through environmental and medicinal sources. AAs are highly nephrotoxic and carcinogenic, mediated by oxidative stress and bioactivation‐induced DNA damage and mutagenicity. Nevertheless, some Lepidoptera, including Pachliopta aristolochiae , feed exclusively on Aristolochiaceae and sequester AAs as a chemical defense. This is uncommon in nature and it is not yet fully understood how these insects avoid the lethal effects of AAs. To address this question, we investigate Pac. aristolochiae ’s AA‐resistance mechanisms by employing metabolic analyses, multiomics analyses, in situ imaging and more. Our findings indicate that AAs may be detoxified through biotransformation and a robust antioxidant system, involving candidate genes such as 15‐oxo‐prostaglandin 13‐reductases ( PGRs ), cytochrome P450s, and catalases. Unexpectedly, DNA adducts, the covalent binding products from activated AA intermediates, are detected across most life stages of Pac. aristolochiae , revealing that Pac. aristolochiae can maintain genomic integrity despite a substantial burden (reaching over 1800 AA‐DNA adducts per 10 8 nucleotides in adults, approximately 1 adduct per 55 000 nucleotides). Interestingly, however, no detectable DNA adducts are observed in wing discs, a representative organ undergoing metamorphosis, and AAs in testes are confined to somatic but not germ cells. Therefore, the strategies to protect against AA‐induced mutagenicity likely include restricted AA distribution in critical tissues and enhanced DNA repair. Using butterflies as an evolutionary model, we identify PTGR1 , the human PGR homolog, as a potential target of AA resistance, which is associated with human acute kidney injury. Validation in human cells further demonstrates its role in reducing AA‐induced cytotoxicity and lipid peroxidation. Our study highlights insect AA tolerance as a means to discover human protective mechanisms, thereby suggesting new avenues for preventing AA‐related diseases.